Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 51, 1996 - Issue 4
4
Views
0
CrossRef citations to date
0
Altmetric
Original articles

Epidemiology Of Microalbuminuria In Type 1 Diabetic Patients (Iddm) in the Antwerp University Hospital

, &
Pages 231-236 | Published online: 16 May 2016

References

  • Andersen AR, Sandahl Christiansen J, Andersen JK, Kreiner S, DeckertT. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia. 1983; 25: 496501.
  • Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mcllilus. Diabetologia. 1985; 28: 590–6.
  • Borch-Johnsen K, Kreiner. Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J. 1987; 294: 1651–54.
  • Mogensen CE, Christensen CK. Predicting diabetic neuropathy in insulin-dependent patients. N Engl J Med. 1984;311:89–93.
  • Viberti GC, Hill RD, Jarrett RJ, Argyropaulos A, Mahmud Y, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982; i: 1430–32.
  • Mathiesen ER, Oxcnboll B, Johansen K, Svendscn PA, DeckertT. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. 1984; 26:406–10.
  • Parving HH, Oxenboll B, Svendscn PA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh). 1982; 100: 550–5.
  • Krempf M, Marre M. La microalbuminurie chez les diabdtiques 1. Definition, intdret et physiopathologie. Diabete Metal). 1987; 13: 225–31.
  • Parving HH, Hommel E, Mathiesen E et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J. 1988; 296: 156–60.
  • Descamps O, Buysschaert M, Ketelslegers JM, Hermans M, Lambert AE. Etude de la microalbuminurie dans une population de 653 patients diabdtiques de type 1 et 2. Diabete Metab. 1991; 17: 469–75.
  • Microalbuminuria Collaborative Study Group. Microalbuminuria in type 1 diabetic patients: prevalence and clinical characteristics. Diabetes Care. 1992; 15:495–501.
  • Krolewski AS, Laffel L, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin dependent diabetes mellitus. N Engl J Med. 1995; 332: 1251–55.
  • Mathiesen ER, Saurbrey N, Hommel E, Parving HH. Prevalence of microalbuminuria in children with type 1 (insulin dependent) diabetes mellitus. Diabetologia. 1986; 29: 640–3.
  • Krolewski AS, Warfam JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type 1 diabetes. Am J Med. 1985; 78: 785–94.
  • Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabete Metab. 1977
  • Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin dependent diabetes mellitus. NEngl J Med. 1993; 329: 977–86.
  • Mauer SM, Steffes MW, Azar S, Sandberg SK, Brown DM. The effect of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes. 1978; 27: 73844.
  • Laffel LM, Krolewski AS, Rand LJ, Warram JH, Christlieb AR, D’Elia JA. The impact of blood pressure on renal function in insulin-dependent diabetes. Kidney Int. 1987; 31: 207 (Abstract).
  • Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J. 1982; 285: 685–8.
  • Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J. 1987; 294: 1443–47.
  • Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993; 329: 1456–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.